Christiana Stamoulis, the Executive Vice President and Chief Financial Officer of Incyte, will leave the company on September 16, 2023, to pursue a new opportunity. Incyte announced her departure on Monday, confirming that she will remain in her position until that date to assist with the transition. The company is currently searching for her successor.
Stamoulis joined Incyte in 2019 and has been instrumental in developing the company’s financial strategy during a significant period of growth and pipeline expansion. Incyte’s President and CEO Bill Meury praised her contributions, stating that she has been “an invaluable part of the leadership team.” He reaffirmed Incyte’s commitment to identifying a strategic leader capable of executing its long-term growth plan.
Company’s Financial Position Remains Strong
Despite the upcoming leadership change, Incyte emphasized that its financial position remains robust. The company reiterated its guidance for 2025, which was initially issued alongside its second-quarter earnings report on July 29, 2023.
Incyte’s strategic direction is unchanged, allowing the organization to continue its focus on expanding its portfolio and advancing its clinical pipeline. The company has expressed confidence in its ability to navigate the transition period effectively while maintaining its growth trajectory.
As Incyte prepares for this leadership transition, the focus will be on ensuring continuity in its financial operations and strategic initiatives. The market will be watching closely as the company seeks to appoint a successor who can build on the foundation laid by Stamoulis and contribute to Incyte’s future success.
